Drugs / Ioversol
Ioversol
also known as
MP 328 · Optiray · Optiray 160 · Optiray 240 · Optiray 300 · Optiray 320 · Optiray 350
Regulatory milestones approvals, filings & regulatory actions · 7 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (6) | US (FDA) | OPTIRAY 350 | — | 1992-01-22 – 1995-06-21 | fda.gov ↗ |
| Approved | US (FDA) | OPTIRAY 350 | — | 1988-12-30 | fda.gov ↗ |
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02117115 | Jun → Oct 2014 | acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome, plasma cell myeloma | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT03631771 | Mar 2022 → Aug 2024 | hypothyroidism | GE Healthcare | Withdrawn | No outcome recorded |
| Phase 4 | NCT00335101 | Jun 2006 → ? | coronary artery disorder, diabetes mellitus, impaired renal function disease | GE Healthcare | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00793182 Comparator | Jan → Jun 2009 | impaired renal function disease | Guerbet | Terminated | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ioversol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00793182 ↗ |
| Known as | MP 328 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200614 ↗ |
| Known as | Optiray | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200614 ↗ |
| Known as | Optiray 160 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200614 ↗ |
| Known as | Optiray 240 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200614 ↗ |
| Known as | Optiray 300 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200614 ↗ |
| Known as | Optiray 320 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200614 ↗ |
| Known as | Optiray 350 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200614 ↗ |
| Modality | Small molecule | — CHEMBL1200614 ↗ |
| Route | Intravenous | “Ioversol administered in the vein” NCT00793182 ↗ |